{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T02:40:38Z","timestamp":1779331238897,"version":"3.51.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,6]],"date-time":"2021-09-06T00:00:00Z","timestamp":1630886400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.vaccine.2021.08.097","type":"journal-article","created":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T07:20:57Z","timestamp":1631344857000},"page":"6081-6087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use"],"prefix":"10.1016","volume":"39","author":[{"given":"Abraham","family":"Palache","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Rockman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverly","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meral","family":"Akcay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John K","family":"Billington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2021.08.097_b0005","unstructured":"World Health Organization. Report of the Third WHO Consultation on the Global Action Plan for Influenza Vaccines. Geneva, Switzerland, 15\u201316 November 2016. Available at: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259727\/WHO-HIS-TTi-17.6-eng.pdf;jsessionid=8226CB8099F043948B45AB5E283D95EA?sequence=1. Accessed April 22, 2021."},{"key":"10.1016\/j.vaccine.2021.08.097_b0010","unstructured":"World Health Organization. Global influenza strategy 2019-2030. World Health Organization; 2019. Available at: http:\/\/www.who.int\/iris\/handle\/10665\/311184. Accessed Aug 2, 2019."},{"key":"10.1016\/j.vaccine.2021.08.097_b0015","unstructured":"World Health Organization. Pandemic Influenza Risk Management: A WHO guide to inform and harmonize national and international pandemic preparedness and response. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. Available at: http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/259893\/WHO-WHE-IHM-GIP-2017.1-eng.pdf;jsessionid=C57DD85154E5CB99358377BA5219ACE5?sequence=1. Accessed April 28, 2021."},{"key":"10.1016\/j.vaccine.2021.08.097_b0020","unstructured":"World Health Organization. WHO Pandemic Influenza Vaccine Response Operational Plan Draft Annotated Outline 1 December 2020. Available at: https:\/\/extranet.who.int\/dataformv3\/upload\/surveys\/776836\/files\/Draft%20WHO%20Pandemic%20Influenza%20Vaccine%20Response%20Operational%20Plan%20Annotated%20Outline_1%20December%202020.pdf. Accessed April 28, 2021."},{"key":"10.1016\/j.vaccine.2021.08.097_b0025","unstructured":"World Health Organization. Influenza Vaccine Response during the Start of a Pandemic. Report of a WHO Informal Consultation held in Geneva, Switzerland, 29 June - 1 July 2015. Available at: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/207751\/WHO_OHE_PED_GIP_2016.1_eng.pdf;sequence=1. Accessed July 29, 2021."},{"key":"10.1016\/j.vaccine.2021.08.097_b0030","unstructured":"World Health Organization. Influenza Vaccine Response during the Start of a Pandemic. Report of the Second WHO Informal Consultation held in Geneva, Switzerland 21 -22 July 2016. Available at: https:\/\/apps.who.int\/iris\/handle\/10665\/254743. Accessed July 29, 2021."},{"key":"10.1016\/j.vaccine.2021.08.097_b0035","unstructured":"World Health Organization. Influenza Vaccine Response During the Start of a Pandemic. Report of the Third WHO informal consultation, 7-9 June 2017, Geneva, Switzerland. Available at: https:\/\/apps.who.int\/iris\/handle\/10665\/325973. Accessed July 29, 2021."},{"key":"10.1016\/j.vaccine.2021.08.097_b0040","unstructured":"Ready2Respond. Available at: https:\/\/ready2respond.org\/. Accessed April 28, 2021."},{"issue":"51","key":"10.1016\/j.vaccine.2021.08.097_b0045","doi-asserted-by":"crossref","first-page":"9459","DOI":"10.1016\/j.vaccine.2011.10.030","article-title":"Seasonal influenza vaccine provision in 157 countries (2004\u20132009) and the potential influence of national public health policies","volume":"29","author":"Palache","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.097_b0050","unstructured":"International Federation of Pharmaceutical Manufacturers and Associations. Influenza vaccine supply (IVS) international task force. Available at: https:\/\/www.ifpma.org\/subtopics\/influenza-vaccine\/. Accessed April 22, 2021."},{"key":"10.1016\/j.vaccine.2021.08.097_b0055","unstructured":"International Federation of Pharmaceutical Manufacturers and Associations. Improving pandemic preparedness. Seasonal influenza vaccination series: Paper 5. 2013. Available at: https:\/\/www.ifpma.org\/wp-content\/uploads\/2016\/01\/IFPMA-IVS-Eng-FactSheet5-01.13.pdf"},{"key":"10.1016\/j.vaccine.2021.08.097_b0060","unstructured":"United Nations Department of Economic and Social Affairs \/ Population Division. World Population Prospects 2019. Available at: https:\/\/population.un.org\/wpp\/Download\/Standard\/Population\/"},{"key":"10.1016\/j.vaccine.2021.08.097_b0065","unstructured":"World Bank. Population, total. Available at: https:\/\/data.worldbank.org\/indicator\/SP.POP.TOTL. Accessed April 28, 2021."},{"key":"10.1016\/j.vaccine.2021.08.097_b0070","unstructured":"OECD. Access to COVID-19 vaccines: Global approaches in a global crisis. March 18, 2021. Available at: https:\/\/www.oecd.org\/coronavirus\/policy-responses\/access-to-COVID-19-vaccines-global-approaches-in-a-global-crisis-c6a18370\/. Accessed May 21, 2021."},{"issue":"4","key":"10.1016\/j.vaccine.2021.08.097_b0075","doi-asserted-by":"crossref","DOI":"10.2196\/26734","article-title":"The impact of the COVID-19 pandemic on the uptake of influenza vaccine: UK-wide observational study","volume":"7","author":"Bachtiger","year":"2021","journal-title":"JMIR Public Health Surveill"},{"key":"10.1016\/j.vaccine.2021.08.097_b0080","unstructured":"Centers for Disease Control and Prevention. Influenza (flu). Weekly National Flu Vaccination Dashboard. Available at: https:\/\/www.cdc.gov\/flu\/fluvaxview\/dashboard\/vaccination-dashboard.html. Accessed April 29, 2021."},{"key":"10.1016\/j.vaccine.2021.08.097_b0085","doi-asserted-by":"crossref","unstructured":"Olsen SJ, Azziz-Baumgartner E, Budd AP et al. Decreased influenza activity during the COVID-19 pandemic \u2014 United States, Australia, Chile, and South AFica, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:1305\u20131309. DOI: http:\/\/dx.doi.org\/10.15585\/mmwr.mm6937a6external icon.","DOI":"10.15585\/mmwr.mm6937a6"},{"key":"10.1016\/j.vaccine.2021.08.097_b0090","unstructured":"Centers for Disease Control and Prevention. Weekly U.S. Influenza Surveillance Report. Available at: https:\/\/www.cdc.gov\/flu\/weekly\/index.htm. Accessed April 29, 2021."},{"key":"10.1016\/j.vaccine.2021.08.097_b0095","unstructured":"World Health Organization. Influenza update \u2013 390. 29 March 2021, based on data up to 14 March 2021. Available at: https:\/\/www.who.int\/publications\/m\/item\/influenza-update-n-390. Accessed July 29, 2021."},{"issue":"12","key":"10.1016\/j.vaccine.2021.08.097_b0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0243833","article-title":"Influenza vaccination hesitancy in five countries of South America. Confidence, complacency and convenience as determinants of immunization rates","volume":"15","author":"Gonz\u00e1lez-Block","year":"2020","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.097_b0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170550","article-title":"Barriers of influenza vaccination intention and behavior \u2013 a systematic review of influenza vaccine hesitancy, 2005\u20132016","volume":"12","author":"Schmid","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2021.08.097_b0110","first-page":"1","article-title":"Which influenza viruses will emerge following the SARS-CoV-2 pandemic?","volume":"00","author":"Laurie","year":"2021","journal-title":"Influenza Other Respi Viruses."},{"key":"10.1016\/j.vaccine.2021.08.097_b0115","unstructured":"World Health Organization. Recommended composition of influenza virus vaccines for use in the 2021-2022 northern hemisphere influenza season. 26 February, 2021. Available at: https:\/\/www.who.int\/publications\/i\/item\/recommended-composition-of-influenza-virus-vaccines-for-use-in-the-2021-2022-northern-hemisphere-influenza-season. Accessed July 29, 2021."},{"issue":"39","key":"10.1016\/j.vaccine.2021.08.097_b0120","doi-asserted-by":"crossref","first-page":"6078","DOI":"10.1016\/j.vaccine.2020.07.058","article-title":"Influenza immunization and COVID-19","volume":"38","author":"Maltezou","year":"2020","journal-title":"Vaccine."},{"key":"10.1016\/j.vaccine.2021.08.097_b0125","unstructured":"Centers for Disease Control and Prevention. Vaccines and immunization. interim clinical considerations for use of COVID-19 vaccines currently authorized in the United States. Available at: https:\/\/www.cdc.gov\/vaccines\/COVID-19\/info-by-product\/clinical-considerations.html#Administration. Accessed April 29, 2021."},{"key":"10.1016\/j.vaccine.2021.08.097_b0130","unstructured":"World Health Organization. Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222, SII Covishield, SK Bioscience). Available at: https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-vaccines-SAGE_recommendation-AZD1222-2021.1"},{"key":"10.1016\/j.vaccine.2021.08.097_b0135","unstructured":"Australian Technical Advisory Group on Immunization (ATAGI). Advice on the relative timing of administering influenza and COVID-19 vaccines in 2021 Version 2.0. Available at: https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2021\/03\/COVID-19-vaccination-atagi-advice-on-influenza-and-COVID-19-vaccines.docx. Accessed April 29, 2021."},{"key":"10.1016\/j.vaccine.2021.08.097_b0140","first-page":"dyab081","article-title":"Interactions between SARS-CoV-2 and influenza, and the impact of coinfection on disease severity: a test-negative design","author":"Stowe","year":"2021","journal-title":"Int J Epidemiol"},{"issue":"47","key":"10.1016\/j.vaccine.2021.08.097_b0145","first-page":"461","article-title":"Vaccines against influenza - WHO position paper \u2013 November 2012","volume":"87","author":"World Health Organization","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.097_b0150","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4161\/hv.8.1.17622","article-title":"Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly","volume":"8","author":"Gasparini","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"8","key":"10.1016\/j.vaccine.2021.08.097_b0155","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1097\/INF.0b013e3182918168","article-title":"Vaccination of healthy children against seasonal influenza: a European perspective","volume":"32","author":"Heikkinen","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2021.08.097_b0160","doi-asserted-by":"crossref","unstructured":"Iuliano AD, Roguski KM, Bresee JS, for the Global Seasonal Influenza-associated Mortality Collaborator Network. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet 2018; 391(10127): 1285-1300. doi: 10.1016\/S0140-6736(17)33293-2. Epub 2017 Dec 14.","DOI":"10.1016\/S0140-6736(17)33293-2"},{"key":"10.1016\/j.vaccine.2021.08.097_b0165","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa041747","article-title":"Risk of myocardial infarction and stroke after acute infection or vaccination","volume":"351","author":"Smeeth","year":"2004","journal-title":"New Engl J Med"},{"key":"10.1016\/j.vaccine.2021.08.097_b0170","unstructured":"US Centers for Disease Control and Prevention. Flu and people with diabetes. Available at: https:\/\/www.cdc.gov\/flu\/highrisk\/diabetes.htm. Accessed Aug 2, 2019."},{"key":"10.1016\/j.vaccine.2021.08.097_b0175","unstructured":"UK Health Protection Agency. Surveillance of Influenza and other Respiratory Viruses in the UK 2010\/2011. London, UK; 2011. Available at: https:\/\/webarchive.nationalarchives.gov.uk\/20140629102627\/http:\/hpa.org.uk\/webc\/HPAwebFile\/HPAweb_C\/1296687414154. accessed Aug 2, 2019."},{"issue":"10","key":"10.1016\/j.vaccine.2021.08.097_b0180","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1093\/eurheartj\/ehm035","article-title":"3rd influenza epidemics and acute respiratory disease activity are associated with a surge in autopsy-confirmed coronary heart disease death: results from 8 years of autopsies in 34,892 subjects","volume":"28","author":"Madjid","year":"2007","journal-title":"EU Heart J"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.097_b0185","first-page":"41","article-title":"Prevention and control of Influenza in persons with Chronic obstructive pulmonary disease","volume":"2","author":"Plans-Rubio","year":"2007","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2021.08.097_b0190","first-page":"1","article-title":"Global seasonal influenza disease and vaccination: a paradox with substantial public health implications","volume":"4","author":"Palache","year":"2018","journal-title":"Int Med Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2021.08.097_b0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118369","article-title":"Estimating influenza disease burden from population-based surveillance data in the United States","volume":"10","author":"Reed","year":"2015","journal-title":"PLoS ONE"},{"issue":"6","key":"10.1016\/j.vaccine.2021.08.097_b0200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066312","article-title":"Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005\u20132011","volume":"8","author":"Kostova","year":"2013","journal-title":"PLoS ONE"},{"issue":"14","key":"10.1016\/j.vaccine.2021.08.097_b0205","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1186\/1471-2458-14-813","article-title":"Annual public health and economic benefits of seasonal influenza vaccination: a European estimate","volume":"7","author":"Preaud","year":"2014","journal-title":"BMC Public Health."},{"issue":"42","key":"10.1016\/j.vaccine.2021.08.097_b0210","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1016\/j.vaccine.2015.08.082","article-title":"Seasonal influenza vaccine dose distribution in 195 countries (2004\u20132013): little progress in estimated global vaccination coverage","volume":"33","author":"Palache","year":"2015","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.vaccine.2021.08.097_b0215","doi-asserted-by":"crossref","first-page":"6369","DOI":"10.1016\/j.vaccine.2014.07.012","article-title":"Seasonal influenza vaccine dose distribution in 157 countries (2004\u20132011)","volume":"32","author":"Palache","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2021.08.097_b0220","doi-asserted-by":"crossref","unstructured":"Palache A, Tsai T, Vasiliev Y, et al. Global influenza vaccine distribution survey demonstrates urgency of implementation of objective 3 of WHO influenza strategy 2019-2030. Internal Medicine Review 2020; 6 (2). Available at: https:\/\/internalmedicinereview.org\/index.php\/imr\/article\/viewFile\/850\/pdf. Accessed April 29, 2021.","DOI":"10.18103\/imr.v6i2.850"},{"issue":"1","key":"10.1016\/j.vaccine.2021.08.097_b0225","first-page":"1","article-title":"Influenza\u2013a preventable disease not being prevented","volume":"134","author":"Mostow","year":"1986","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.vaccine.2021.08.097_b0230","article-title":"Steps toward a universal influenza vaccine: research models and comparison of current approaches. In Steps Forwards in Diagnosing and Controlling Influenza","author":"Wong","year":"2016","journal-title":"IntechOpen. Ed Manal Mohammad Baddour."},{"key":"10.1016\/j.vaccine.2021.08.097_b0235","unstructured":"National Institutes of Allergy and Disease. Universal influenza vaccine research. Available at: https:\/\/www.niaid.nih.gov\/diseases-conditions\/universal-influenza-vaccine-research. Accessed April 29, 2021."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011579?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21011579?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:02:21Z","timestamp":1759402941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21011579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":47,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0264410X21011579"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.097","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine complacency and dose distribution inequities limit the benefits of seasonal influenza vaccination, despite a positive trend in use","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.097","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}